Regulation of LFA-3 (CD58) by dexamethasone and retinoic acids in vitro

Inflammation Research

Volumn 49, Issue 7, 2000, Pages 338-

  Cahen, P ^a   Kirby, A C ^a   Porter, S R ^a   Olsen, I ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cell Lines; Glucocorticoids; LFA 3 (CD58); Lichen Planus; Retinoids

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; ISOTRETINOIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; CELL STRAIN KB; CELL STRAIN U937; FLOW CYTOMETRY; HUMAN; LEUKEMIA CELL LINE;

ANTIGENS, CD58; DEXAMETHASONE; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; ISOTRETINOIN; JURKAT CELLS; KB CELLS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS; TRETINOIN; U937 CELLS;

EID: 0034221717     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000214     Document Type: Article

References (52)

1. Springer TA , Dustin ML, Kishimoto TK, Marlin SD. The lymphocytes function associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Ann Rev Immunol 1987; 5: 223-32.
2. Seed B. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature 1987; 329: 840-2.
3. Selvaraj P, Plunkett ML, Dustin M, Sanders ME, Shaw S, Springer TA. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature 1987; 326: 400-3.
4. Koyasu S, Lawton T, Novick D, Recny MA, Siliciano RF, Wallner BP et al. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. Proc Natl Acad Sci USA. 1990; 87: 2603-7.
5. Wingren AG, Parra E, Varga M, Kalland T, Sjogren HO, Hedlund G et al. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol 1995; 15: 235-53.
6. Hodge JW, Sabzevari H, Yafal AG, Gritz L, Lorenz MG, Schlom J. A triad of costimulatory molecules synergize to amplify T-cell activation. Cancer Res 1999; 59: 5800-7.
7. Dustin ML, Olive D, Springer TA. Correlation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function-associated antigen 3. J Exp Med 1989; 169: 503-17.
8. Street D, Kaufmann AM, Vaughan A, Fisher SG, Hunter M, Schreckenberger C et al. Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells. Gynecol Oncol 1997; 65: 265-72.
9. Tissot C, Rebouissou C, Klein B, Mechti N. Both human alpha/beta and gamma interferons upregulate the expression of CD48 cell surface molecules. J Interferon Cytokine Res 1997; 17: 17-26.
10. Wallich R, Brenner C, Brand Y, Roux M, Reister M, Meuer S. Gene structure, promoter characterization, and basis for alternative mRNA splicing of the human CD58 gene. J Immunol 1998; 160: 2862-71.
11. Hoffmann JC, Dengler TJ, Knolle PA, Albert-Wolf M, Roux M, Wallich R et al. A soluble form of the adhesion receptor CD58 (LFA-3) is present in human body fluids. Eur J Immunol 1993; 23: 3003-10.
12. Autschbach F, Meuer SC, Moebius U, Manns M, Hess G, Meyer zum Buschenfelde K et al. Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis. Hepatology 1991; 14: 223-30.
13. Crawford JM. Distribution of ICAM-1, LFA-3 and HLA-DR in healthy and diseased gingival tissues. J Periodontal Res 1992; 27: 291-8.
14. Kirby AC, Olsen I, Farthing PM, Porter R. Expression of lymphocyte-function-associated-antigen 3 in oral lichen planus. Oral Dis 1995; 1: 193-7.
15. Scully C, Beyli M, Ferreiro MC, Ficarra G, Gills Y, Griffiths M, Holmstrup P et al. Update on oral lichen planus ethiopathogenesis and management. Crit Rev Oral Biol Med 1998; 9: 86-122.
16. Farmer ER. The histopathology of graft-versus-host disease. Adv Dermatol 1986; 1: 173-88.
17. Saito K, Tamura A, Narimatsu H, Tadakuma T, Nagashima M. Cloned auto-Ia-reactive T cells elicit lichen planus-like lesion in the skin of syngeneic mice. J Immunol 1986; 137: 2485-95.
18. Farthing PM, Matear P, Cruchley AT. Langerhans cell distribution and keratinocyte expression of HLA-DR in oral lichen planus. J Oral Pathol Med 1992; 21: 451-5.
19. Pittagala-Arachchi A, Crane IJ, Scully, Prime S. Epithelial dendritic cells in pathological human oral tissues. J Oral Pathol Med 1989; 18: 11-6.
20. Walsh LJ, Savage NW, Ashii T, Seymour GJ. Immunopathogenesis of oral lichen planus. J Oral Pathol Med 1990; 19: 389-396.
21. Sugermann PB, Savage N W, Seymour G J, Walsh LJ. Is there a role for tumor necrosis factor-alpha (TNF-alpha) in oral lichen planus? J Oral Pathol Med 1996; 25: 219-24.
22. Yamamoto T, Osaki T, Yoneda K, Ueta E. Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus. J Oral Pathol Med 1994; 23: 309-15.
23. Younes F, Quartey EL, Kiguwa S, Partridge M. Expression of TNF and the 55-kDa TNF receptor in epidermis, oral mucosa, lichen planus and squamous cell carcinoma. Oral Dis 1996; 2: 25-31.
24. Regezi JA, Stewart JC, Lloyd RV, Headington JT. Immunohistochemical staining of Langerhans cells and macrophages in oral lichen planus. Oral Surg Oral Med Oral Pathol 1985; 60: 396-402.
25. Walton LJ, Thornhill MH, Farthing PM. VCAM-1 and ICAM-1 are expressed by Langerhans cells, macrophages and endothelial cells in oral lichen planus. J Oral Pathol Med 1994; 23: 262-8.
26. Eisen D. The therapy of oral lichen planus. Crit Rev Oral Biol Med 1993; 4: 141-58.
27. Weigel NL. Steroid hormone receptors and their regulation by phosphorylation. Biochem J 1996; 319: 657-67.
28. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids: biology, chemistry and medicine, 2nd edition. New York: Raven Press, 1994: 314-49.
29. Pitzalis C, Pipitone N, Bajocchi G, Hall M, Goulding N, Lee A et al. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect. J Immunol 1997; 158: 5007-16.
30. Gille J, Paxton LL, Lawley TJ, Caughman SW, Swerlick RA. Retinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cells. J Clin Invest 1997; 99: 492-500.
31. Brotsjan C, Anrather J, Csizmadia V, Natarajan G, Winkler H. Glucocorticoids inhibit E-selectin expression by targetting NF-kappaB and not ATF/c-jun. J Immunol 1997; 158: 3836-44.
32. Albanesi C, Pastore S, Fanales-Belasio E, Girolomoni G. Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy 1998; 28: 101-9.
33. Atsuta J, Plitt J, Bochner BS, Schleimer RP. Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. Am J Respir Cell Mol Biol 1999; 20: 643-50.
34. Tessier PA, Cattaruzzi P, McColl SR. Inhibition of lymphocyte adhesion to cytokine-activated synovial fibroblasts by glucocorticoids involves the attenuation of vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 gene expression. Arthritis Rheum 1996; 39: 226-34.
35. Tessier P, Audette M, Cattaruzzi P, McColl SR. Up-regulation by tumor necrosis factor alpha of intercellular adhesion molecule 1 expression and function in synovial fibroblasts and its inhibition by glucocorticoids. Arthritis Rheum 1993; 36: 1528-39.
36. Weber C, Calzada-Wack JC, Goretzki M, Pietsch A, Johnson JP, Ziegler-Heitbrock HW. Retinoic acid inhibits basal and interferon-gamma-induced expression of intercellular adhesion molecule 1 in monocytic cells. J Leuk Biol 1995; 57: 401-6.
37. Hollander N. Membrane dynamics of the phosphatidylinositol-anchored form and the transmembrane form of the cell adhesion protein LFA-3. J Biol Chem 1992; 267: 5663-7.
38. Wallner BP, Frey AZ, Tizard R, Mattaliano RJ, Hession C, Sanders ME et al. Primary structure of lymphocyte function-associated antigen 3 (LFA-3) The ligand of the T lymphocyte CD2 glycoprotein. J Exp Med 1987; 166: 923-32.
39. Xie Z, Bikle DD. Differential regulation of vitamin D responsive elements in normal and transformed keratinocytes. J Invest Dermatol 1998; 110: 730-3.
40. Deckert M, Ticchioni M, Bernard A. Endocytosis of GPI-anchored proteins in human lymphocytes: role of glycolipid-based domains, actin cytoskeleton, and protein kinases. J Cell Biol 1996; 133: 791-9.
41. Baier R, Bondeva T, Klinger R, Bondev A, Wetzker R. Retinoic acid induces selective expression of phosphoinositide 3-kinase gamma in myelomonocytic U937 cells. Cell Growth Differ. 1999; 10: 447-56.
42. Iademarco M, McQuillan J, Rosen G, Dean D. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992; 267: 16323-9.
43. Degitz K, Lian-Jie L, Caughman S. Cloning and characterization of the 5′-transcriptional regulatory region of the human intercellular adhesion molecule-1 gene. J Biol Chem 1991; 266: 14024-30.
44. Hromas R, Orazi A, Neiman RS, Maki R, Van Beveran C, Moore J et al. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood 1993; 82: 2998-3004.
45. Wanner R, Zhang J, Henz BM, Rosenbach T. AP-2 gene expression and modulation by retinoic acid during keratinocyte differentiation. Biochem Biophys Res Commun 1996; 223: 666-9.
46. Gorovits R, Ben-Dror I, Fox LE, Westphal HM, Vardimon L. Developmental changes in the expression and compartimentalization of the glucocorticoid receptor in embryonic retina. Proc Natl Acad Sci USA 1994; 89: 6731-5.
47. Aström A, Pettersson U, Krust A, Chambon P, Voorhees JJ. Retinoic acid and synthetic analogs differentially activate retinoic acid receptor dependent transcription. Biochem Biophys Res Commun 1990; 173: 339-45.
48. Teunissen MBM. Functional role of adhesion molecules LFA-3 and ICAM-1 on cultured human epidermal Langerhans cells in antigen-specific T-cell activation. J Invest Derm 1992; 99: 7-9S.
49. Piela TH, Korn JH. ICAM-1-dependent fibroblast-lymphocyte adhesion: discordance between surface expression and function of ICAM-1. Cell Immunol 1990; 129: 125-37.
50. Stewart MP, Cabanas C, Hogg N. T cell adhesion to intercellular adhesion molecule-1 (ICAM-1) is controlled by cell spreading and the activation of integrin LFA-1. J Immunol 1996; 156: 1810-7.
51. Kirby AC, Cahen P, Porter SR, Olsen I. LFA-3 (CD58) mediates T lymphocytes adhesion in chronic inflammatory infiltrates. Scand J Immunol. 1999; 50: 469-74.
52. Sultan P, Schechner JS, McNiff JM, Hochman PS, Hughes CCW, Lorber MI et al. Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras. Nature Biotechnology 1997; 15: 759-62.